Macular Degeneration is reaching epidemic proportions and risk assessment for this sight-threatening condition has always been a challenge...

      Until Now!

ZeaVision’s new program, QuantifEYE, now gives us the means to determine potential risk for macular degeneration. This program is affordable, results are measurable, and testing is convenient. Baby Boomers are a generation now facing the challenges of macular degenertion. Early risk assessment and prevention needs to start with patients in their 20’s. Our goal is to do everything possible to keep your vision healthy for years to come, and QuantifEYE is another way we can assist you in that goal.

QuantifEye is a comprehensive risk assessment that includes an evaluation of potential health/history factors, measurement of your macular pigment levels, and your retinal exam. This approach ensures everything possible is being done to aid in the prevention of this devastating disease. 

Ask us about this latest technology and ways that may help prevent your development of macular degeneration.

Visit http://www.zeavision.com for more information.